Ranch Capital Advisors Inc. Vertex Pharmaceuticals Inc Transaction History

Ranch Capital Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $8,850 - $11,172	-50 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2,358 - $2,638	-13 Reduced 20.63%	50 $9,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $2,812 - $3,316	-15 Reduced 19.23%	63 $12,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $81,358 - $94,834	-393 Reduced 83.44%	78 $16,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $92,947 - $123,964	-449 Reduced 48.8%	471 $111,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $14,060 - $16,670	55 Added 6.36%	920 $256,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $195,040 - $255,867	865 New	865 $232,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.